The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 601–700 of 1,044

1. A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
   Connell, John M. C., MacKenzie, Scott M., Freel, E. Marie, Fraser, Robert, Davies, Eleanor · 2008 · Endocrine Reviews
2. Determination of the clinical importance of study results
   Malcolm Man‐Son‐Hing, Andreas Laupacis, Keith O’Rourke, Frank Molnar, Jeffery Mahon, Karen B Y Chan, George A. Wells · 2002 · Journal of General Internal Medicine
3. Improvement in Blood Pressure With Inhibition of the Epithelial Sodium Channel in Blacks With Hypertension
   C. Saha, G. Eckert, W. Ambrosius, T. Chun, M. A. Wagner, Qian-Qian Zhao, J. Pratt · 2005 · HYPERTENSION
4. Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
   Gunnar Gislason, Jeppe Nørgaard Rasmussen, Steen Zabell Abildstrom, Tina Ken Schramm, Morten Lock Hansen, Pernille Buch, Rikke Sørensen, Fredrik Folke, Niels Gadsbøll, Søren Rasmussen et al. · 2007 · Circulation
5. Aldosterone Synthase Inhibitor Ameliorates Angiotensin II–Induced Organ Damage
   Anette Fiebeler, Jürg Nussberger, Erdenechimeg Shagdarsuren, Song Rong, Georg Hilfenhaus, Nidal Al‐Saadi, Ralf Dechend, Maren Wellner, Silke Meiners, Christiane Maser‐Gluth et al. · 2005 · Circulation
6. Sex and Gender Differences in Heart Failure
   Vera Regitz‐Zagrosek · 2020 · International Journal of Heart Failure
7. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation
   Stacey J. Wieczorek, Alan H.B. Wu, Robert H. Christenson, Padma Krishnaswamy, Stephen S. Gottlieb, THOMAS G. ROSANO, David R. Hager, Nancy J. Gardetto, Albert Chiu, Kathryn R. Bailly et al. · 2002 · American Heart Journal
8. Multicenter Randomized Trial of a Comprehensive Hospital Discharge and Outpatient Heart Failure Management Program
   Felipe Atienza, Manuel P. Anguita, Nieves Martínez‐Alzamora, Joaquín Osca, Soledad Ojeda, Luis Almenar Bonet, Francisco Ridocci, Federico Vallés, José A. Velasco · 2004 · European Journal of Heart Failure
9. Diastolic heart failure in anaesthesia and critical care
   Romain Pirracchio, Bernard Cholley, Stefan G. De Hert, Alain Cohen Solal, Alexandre Mebazaa · 2007 · British Journal of Anaesthesia
10. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
    Neha Bansal, M. Jacob Adams, Sarju Ganatra, Steven D. Colan, Sanjeev A. Aggarwal, Rudolf K. Steiner, Shahnawaz M. Amdani, Emma R. Lipshultz, Steven E. Lipshultz · 2019 · Cardio-Oncology
11. Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside
    Kolkhof, Peter, Jaisser, Frederic, Kim, So-Young, Filippatos, Gerasimos, Nowack, Christina, Pitt, Bertram · 2016 · Handbook of Experimental Pharmacology
12. Regulation of aldosterone synthesis and secretion.
    Bollag, Wendy B. · 2014 · Comprehensive Physiology
13. Cytochrome P450 enzymes: Central players in cardiovascular health and disease
    Reem H. Elbekai, Ayman O.S. El‐Kadi · 2006 · Pharmacology & Therapeutics
14. Mineralocorticoid receptors in vascular function and disease
    Amy McCurley, Iris Zamir Jaffe · 2011 · Molecular and Cellular Endocrinology
15. Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
    Faiez M. Zannad, Wendy Gattis Stough, Patrick Rossignol, Johann Bauersachs, John J.V. McMurray, Karl B Swedberg, Allan D. Struthers, A.A. Voors, Luis Miguel Ruilope, George L. Bakris et al. · 2012 · European Heart Journal
16. Age-related Changes in Venticular–Arterial Coupling: Pathophysiologic Implications
    David A. Kass · 2002 · Heart Failure Reviews
17. Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure -
    Tatsuo Aoki, Yoshihiro Fukumoto, Koichiro Sugimura, Minako Oikawa, Kimio Satoh, Makoto Nakano, Masaharu Nakayama, Hiroaki Shimokawa · 2011 · Circulation Journal
18. Atrial Fibrillation: Mechanisms, Therapeutics, and Future Directions
    Jason Pellman, Farah Sheikh · 2015 · Comprehensive physiology
19. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
    Giuseppe M.C. Rosano, Basil S. Lewis, Stefan Agewall, Sven Waßmann, Cristiana Vitale, Harald H.H.W. Schmidt, Heinz Drexel, Atul Patak, Christian Tobias Torp-Pedersen, Keld Per Kjeldsen et al. · 2015 · European Heart Journal
20. Gender Differences in Patients with Heart Failure
    Anna Strömberg, Jan Mårtensson · 2003 · European Journal of Cardiovascular Nursing
21. Medical Therapy for Heart Failure Caused by Ischemic Heart Disease
    Islam Y. Elgendy, Dhruv Mahtta, Carl J. Pepine · 2019 · Circulation Research
22. Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease
    Ulrich Kintscher, George L. Bakris, Peter Kolkhof · 2021 · British Journal of Pharmacology
23. Cardiomyopathies: from genetics to the prospect of treatment
    Wolfgang-M. Franz, Oliver Josef Müller, Hugo Albert Katus · 2001 · The Lancet
24. Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart Failure
    Harsh B. Golwala, Ambarish Pandey, Christine Ju, Javed Butler, Clyde W. Yancy, Deepak L. Bhatt, Adrian F. Hernandez, Gregg C. Fonarow · 2015 · Journal of the American College of Cardiology
25. Therapeutic targets for cardiac fibrosis: from old school to next-gen
    Joshua G. Travers, Charles A. Tharp, Marcello Rubino, Timothy A. McKinsey · 2022 · Journal of Clinical Investigation
26. Human Mineralocorticoid Receptor Expression Renders Cells Responsive for Nongenotropic Aldosterone Actions
    Claudia Großmann, Andreas Benesic, Alexander W. Krug, Ruth Freudinger, Sigrid Mildenberger, Birgit Gaßner, Michael Gekle · 2005 · Molecular Endocrinology
27. Treatment of Hypertension in Patients With Coronary Artery Disease
    Clive Rosendorff, Daniel T. Lackland, Matthew Allison, Wilbert S. Aronow, Henry R. Black, Roger Scott Blumenthal, Christopher Paul Cannon, James A. de Lemos, W.J. Elliott, Laura Findeiss et al. · 2015 · Hypertension
28. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
    Peter D. Collins, Giuseppe M.C. Rosano, C. Casey, Caroline Daly, Marco Gambacciani, Peyman Hadji, Risto Kaaja, Tomi S. Mikkola, Santiago Palacios, Richard Arthur Preston et al. · 2007 · European Heart Journal
29. The renin-angiotensin-aldosterone system and its therapeutic targets
    Katrina M. Mirabito Colafella, Dominique M. Bovée, A.H. Jan Danser · 2019 · Experimental Eye Research
30. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)
    Gianluigi Savarese, Johan Bodegård, Anna Norhammar, Peter Sartipy, Marcus Thuresson, Martín Cowie, Gregg C. Fonarow, Muthiah Vaduganathan, Andrew J.S. Coats · 2021 · European Journal of Heart Failure
31. Vascular Actions of Aldosterone
    Marie B Briet, Ernesto L. Schiffrin · 2012 · Journal of Vascular Research
32. The Kidney in Congestive Heart Failure: ‘are Natriuresis, Sodium, and Diuretics Really the Good, the Bad and the Ugly?’
    Frederik Hendrik Verbrugge, Matthias Dupont, Paul Steels, Lars Grieten, Q. Swennen, W.H. Wilson Tang, Wilfried Müllens · 2013 · European Journal of Heart Failure
33. High output heart failure
    P.A. Mehta, Simon William Dubrey · 2008 · QJM
34. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction
    Neville Suskin, Tej Sheth, Abdissa Negassa, Salim Yusuf · 2001 · Journal of the American College of Cardiology
35. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
    Tomaschitz, A., Pilz, S., Ritz, E., Meinitzer, A., Boehm, B. O., Marz, W. · 2010 · European Heart Journal
36. Review: Diagnosis and management of primary aldosteronism
    Michael Stowasser, Richard D. Gordon, John C. Rutherford, Nik Z Nikwan, Nicholas Daunt, Gregory J. Slater · 2001 · Journal of the Renin-Angiotensin-Aldosterone System
37. Effects of Telmisartan Added to Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Hemodialysis Patients With Chronic Heart Failure
    Gennaro Cice, Attilio Di Benedetto, Salvatore D’Isa, Antonello D’Andrea, Daniele Marcelli, Emanuele Gatti, Raffaele Calabrò · 2010 · Journal of the American College of Cardiology
38. Cardiorenal Syndrome in Acute Decompensated Heart Failure
    Mohammad Sarraf, Amirali Masoumi, Robert W. Schrier · 2009 · Clinical Journal of the American Society of Nephrology
39. Primary Aldosteronism
    James Brian Byrd, Adina F. Turcu, Richard Joseph Auchus · 2018 · Circulation
40. Incidence and Predictors of Hyperkalemia in Patients With Heart Failure
    Desai, Akshay S., Swedberg, Karl, McMurray, John J.V., Granger, Christopher B., Yusuf, Salim, Young, James B., Dunlap, Mark E., Solomon, Scott D., Hainer, James W., Olofsson, Bertil et al. · 2007 · Journal of the American College of Cardiology
41. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management
    Mark T. Kearney, James M. Cotton, Peter J. Richardson, Ajay M. Shah · 2001 · Postgraduate Medical Journal
42. Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update
    Jeffrey Smith, Jenna Negrelli, Megha Manek, Emily M. Hawes, A. J. Viera · 2015 · The Journal of the American Board of Family Medicine
43. Involvement of oxidative stress in the profibrotic action of aldosteroneInteraction with the renin-angiotensin system
    Marc Iglarz, Rhian M. Touyz, Émilie C. Viel, Farhad Amiri, Ernesto L. Schiffrin · 2004 · American Journal of Hypertension
44. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity Commentary: Time for a controlled trial?
    Mario C.-H.K. Deng, J. M. J. De Meester, Jacqueline M. Smits, Jay W. Heinecke, H.H. Scheld, Tom Treasure, A. Murday · 2000 · BMJ
45. Aldosterone and Angiotensin II Synergistically Induce Mitogenic Response in Vascular Smooth Muscle Cells
    Li‐Juan Min, Masaki Mogi, Jian‐Mei Li, Jun Iwanami, Masaru Iwai, Masatsugu Horiuchi · 2005 · Circulation Research
46. The science of steroids
    Timothy James Cole, Kelly Short, Stuart B. Hooper · 2019 · Seminars in Fetal and Neonatal Medicine
47. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001
    Hanna Blackledge, J Tomlinson, I B Squire · 2003 · Heart
48. Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction
    Daniela Fraccarollo, Paolo Galuppo, Steven K. Hildemann, Michael Christ, Georg Ertl, Johann K Bauersachs · 2003 · Journal of the American College of Cardiology
49. Diuretics
    George C. Roush, Ramdeep Kaur, Michael E. Ernst · 2013 · Journal of Cardiovascular Pharmacology and Therapeutics
50. Dilated cardiomyopathy: a review
    Andrea O. Y. Luk, Eric Ahn, Gursharan S. Soor, JAGDISH W. BUTANY · 2008 · Journal of Clinical Pathology
51. Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure
    João Pedro Ferreira, Faiez M. Zannad, Stuart Pocock, Stefan D. Anker, Javed Butler, Gerasimos S Filippatos, Martina Brueckmann, Waheed Jamal, Dominik Steubl, Elke Schueler et al. · 2021 · Journal of the American College of Cardiology
52. Ace inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension
    T Morgan · 2001 · American Journal of Hypertension
53. Steroidogenic Enzyme Gene Expression in the Human Heart
    Kathleen M. Kayes, Perrin C. White · 2000 · The Journal of Clinical Endocrinology & Metabolism
54. New Therapeutic Options in Congestive Heart Failure: Part I
    John J.V. McMurray, Marc Alan Pfeffer · 2002 · Circulation
55. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006
    Henry Krum, Michael V Jelinek, Simon Stewart, Andrew Paul Sindone, John James Atherton, Anna L. Hawkes · 2006 · The Medical Journal of Australia
56. 20 Years of Cardiac Resynchronization Therapy
    Francisco Leyva, Seah Nisam, Angelo Auricchio · 2014 · Journal of the American College of Cardiology
57. Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients
    Carmine Savoia, Rhian M. Touyz, Farhad Amiri, Ernesto L. Schiffrin · 2008 · Hypertension
58. The Role of Aldosterone in Obesity-Related Hypertension
    Wakako Kawarazaki, Toshiro Fujita · 2016 · American Journal of Hypertension
59. Medical Treatment of Aortic Stenosis
    Guillaume Marquis‐Gravel, Björn Redfors, Martin B. Leon, Philippe Généreux · 2016 · Circulation
60. Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone
    Jean‐Claude Aldigier, Talerngsak Kanjanabuch, Lijun Ma, Nancy Jeanne Brown, Agnes B. Fogo · 2005 · Journal of the American Society of Nephrology
61. The neuroretina is a novel mineralocorticoid target: aldosterone up‐regulates ion and water channels in Müller glial cells
    Min Zhao, Fatemeh Valamanesh, Isabelle Célérier, Michèle Savoldelli, Laurent Jonet, Jean‐Claude Jeanny, Frédéric Jaisser, Nicolette Farman, Francine Béhar‐Cohen · 2010 · The FASEB Journal
62. Diuretics and Ultrafiltration in Acute Decompensated Heart Failure
    Gary Michael Felker, Robert John Mentz · 2012 · Journal of the American College of Cardiology
63. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials
    Justin Adrian Ezekowitz, Finlay Aleck McAlister · 2008 · European Heart Journal
64. Predictors of Hyperkalemia and Death in Patients With Cardiac and Renal Disease
    Renee E. Garrick · 2012 · Yearbook of Medicine
65. Pharmacotherapy for Heart Failure in Patients with Renal Insufficiency
    Michael G. Shlipak · 2003 · Annals of Internal Medicine
66. Conventional heart failure therapy in cardiac ATTR amyloidosis
    Adam Ioannou, Paolo Massa, Rishi K Patel, Yousuf Razvi, Aldostefano Porcari, Muhammad Umaid Rauf, Anita Jiang, Giacomo Cabras, Stefano Filisetti, Roos Eline Bolhuis et al. · 2023 · European Heart Journal
67. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery
    Magdi Habib Yacoub · 2001 · European Heart Journal
68. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction
    Masaru Hayashi, Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda, Naoko Mabuchi, Takashi Tsutsui, Hajime Horie, Masato Ohnishi, Masahiko Kinoshita · 2001 · Journal of the American College of Cardiology
69. Prediction and Management of Hyperkalemia Across the Spectrum of Chronic Kidney Disease
    Lazich, Ivana, Bakris, George L. · 2014 · Seminars in Nephrology
70. Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)
    Salvatore Paterna, Sergio Fasullo, Sergio Cannizzaro, Gabriella Vitrano, Gabriella Terrazzino, Giorgio Maringhini, Filippo Ganci, Sebastiano Scalzo, Pietro Di Pasquale, Gaspare Parrinello et al. · 2011 · The American Journal of the Medical Sciences
71. Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs
    Cécile Konrat, Isabelle Boutron, Ludovic Trinquart, G.-R. Auleley, Philippe Ricordeau, Philippe Ravaud · 2012 · PLoS ONE
72. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research
    Kalipso Chalkidou, Sean Tunis, Danielle M. Whicher, Robert Fowler, Merrick Zwarenstein · 2012 · Clinical Trials
73. Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis
    Pardeep S. Jhund, Atefeh Talebi, Alasdair David Henderson, Brian Lee Claggett, Muthiah Vaduganathan, Akshay Suvas Desai, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv Jayendra Shah et al. · 2024 · The Lancet
74. Molecular Mechanisms of Myocardial Remodeling. The Role of Aldosterone
    Claude Delcayre · 2002 · Journal of Molecular and Cellular Cardiology
75. Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
    Ernesto Martínez‐Martínez, Laurent Calvier, Amaya Fernández‐Celis, Elodie Rousseau, Raquel Jurado-López, Luciana Venturini Rossoni, Frédéric Jaisser, Faiez M. Zannad, Patrick Rossignol, Victoria Cachofeiro et al. · 2015 · Hypertension
76. Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension
    Willa A. Hsueh, Kathleen Louise Wyne · 2011 · Journal of Clinical Hypertension
77. Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021
    José Carlos Nicolau, Gilson Soares Feitosa, João Luiz Fernandes Petriz, Remo Holanda de Mendonça Furtado, Dalton Bertolim Précoma, Walmor Lemke, Renato D. Lópes, Ari Timerman, José Antônio Marin‐Neto, Luiz Bezerra et al. · 2021 · Arquivos Brasileiros de Cardiologia
78. Rapid evidence‐based sequencing of foundational drugs for heart failure and a reduced ejection fraction
    Milton Packer, John J.V. McMurray · 2021 · European Journal of Heart Failure
79. Use of Evidence-Based Therapy and Survival in Heart Failure in Sweden 2003–2012
    Tonje Thorvaldsen, Lina Benson, Ulf Dahlström, Magnus Edner, Lars H. Lund · 2016 · European Journal of Heart Failure
80. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure
    Aurélie Nguyen Dinh Cat, Violaine Griol‐Charhbili, Laurent Loufrani, Carlos Labat, Laura E. Benjamin, Nicolette Farman, Patrick J. Lacolley, Daniel Henrion, Frédéric Jaisser · 2010 · The FASEB Journal
81. JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure
    Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito et al. · 2021 · Journal of Cardiac Failure
82. Management of chronic heart failure in the older population.
    Nahid Azad, Geneviève Lemay · 2014 · Europe PMC (PubMed Central)
83. Stage B Heart Failure
    Lee R. Goldberg, Mariell L Jessup · 2006 · Circulation
84. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials
    Catherine L. Tacon, John McCaffrey, Anthony P. Delaney · 2011 · Intensive Care Medicine
85. Cardiomyopathy, familial dilated
    Matthew R.G. Taylor, Elisa Carniel, Luisa Mestroni · 2006 · Orphanet Journal of Rare Diseases
86. Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
    Liviu Segall, Ionuţ Nistor, Adrian Constantin Covic · 2014 · BioMed Research International
87. Evaluating Quality of Care for Patients With Heart Failure
    Harlan M. Krumholz, David W. Baker, Carol M. Ashton, Sandra Barker Dunbar, Gottlieb C. Friesinger, Edward P. Havranek, Mark Andrew Hlatky, Marvin A. Konstam, Diana L. Ordin, Ileana L. Piña et al. · 2000 · Circulation
88. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
    Michelle Maya Kittleson, Shelley Hurwitz, Monica Shah, Anju Nohria, Eldrin Foster Lewis, Michael M. Givertz, James Chen-Tson Fang, John Adams Jarcho, Gilbert H. Mudge, Lynne Warner Stevenson · 2003 · Journal of the American College of Cardiology
89. Perioperative Management of Chronic Heart Failure
    Leanne Groban, John F. IV Butterworth · 2006 · Anesthesia & Analgesia
90. Effect of Patiromer on Reducing Serum Potassium and Preventing Recurrent Hyperkalaemia in Patients with Heart Failure and Chronic Kidney Disease on Raas Inhibitors
    Bertram Pitt, George L. Bakris, David A. Bushinsky, Dahlia Garza, Martha R. Mayo, Yuri Stasiv, Heidi Christ‐Schmidt, Lance Berman, Matthew R. Weir · 2015 · European Journal of Heart Failure
91. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity
    Nicola Schäfer, Christine Lohmann, Stephan H. Winnik, Lambertus J. van Tits, Melroy X Miranda, Athanasios Vergopoulos, Frank Thomas Ruschitzka, Jürg Nussberger, Stefan Berger, Thomas Felix Lüscher et al. · 2013 · European Heart Journal
92. Primary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney
    Michael Stowasser, Richard D. Gordon · 2016 · Physiological Reviews
93. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
    Kok-Meng Yee, Stuart D. Pringle, Allan D. Struthers · 2001 · Journal of the American College of Cardiology
94. Catabolism in chronic heart failure
    Colin Berry · 2000 · European Heart Journal
95. Demographics and concomitant disorders in heart failure
    Henry Krum, Richard E. Gilbert · 2003 · The Lancet
96. Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance
    Shawn B. Bender, Adam P. McGraw, Iris Zamir Jaffe, James R. Sowers · 2013 · Diabetes
97. Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
    John W. Funder · 2017 · International Journal of Molecular Sciences
98. Heart failure
    Henry Krum, William T. Abraham · 2009 · The Lancet
99. Eplerenone
    Nancy Jeanne Brown · 2003 · Circulation
100. Treatment of Congestive Heart Failure
     Faiez M. Zannad, Brigitte Dousset, François Alla · 2001 · Hypertension